In other H5N1 developments, the FDA's vaccine advisory group said it will discuss the composition of H5 vaccines when it ...
AZ, which owns FluMist through its $15.6 billion purchase of US biotech MedImmune (pictured) in 2007, said the CDC's effectiveness data contrasted with its own studies, as well as preliminary ...
This week, MedImmune celebrates its 25th anniversary – and has come to represent half of AstraZeneca’s research and development pipeline. Best known, perhaps, as the maker of FluMist ...
Tim has published more than a dozen Kellogg case studies including Crestor, MedImmune: FluMist Introduction and Genzyme: the Synvisc-One Investment Decision. In a competitive market, brands have ...
Sanofi's 4-in-1 influenza vaccine joins GlaxoSmithKline's Fluarix Quadrivalent and AstraZeneca's MedImmune FluMist Quadrivalent that are already approved for use in the United States. MSD and ...